Erlocip 150 Tablet Benefits & Uses

Erlocip 150 Tablet is used to treat the following -

Main Benefits

Pancreatic Cancer
Non-Small Cell Lung Cancer

Erlocip 150 Tablet Dosage & How to Take

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Age Group	Dosage
Adult	Disease: Non-Small Cell Lung Cancer Before or After Meal: Either Single Maximum Dose: 150 mg Dosage Form: Tablet Dosage Route: Oral Frequency: 1 daily Course Duration: As directed by the doctor Special Instructions: As prescribed by the doctor
Geriatric	Disease: Non-Small Cell Lung Cancer Before or After Meal: Either Single Maximum Dose: 150 mg Dosage Form: Tablet Dosage Route: Oral Frequency: 1 daily Course Duration: As directed by the doctor Special Instructions: As prescribed by the doctor

Erlocip 150 Tablet Related Warnings

Is the use of Erlocip 150 Tablet safe for pregnant women?

Erlocip can have harmful effects in pregnant women. If you experience any discomfort after using Erlocip, then discontinue the use and take your doctor's advice.

Moderate
Is the use of Erlocip 150 Tablet safe during breastfeeding?

Erlocip can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.

Moderate
What is the effect of Erlocip 150 Tablet on the Kidneys?

Erlocip is completely safe for kidneys.

Safe
What is the effect of Erlocip 150 Tablet on the Liver?

You may experience side effects on your liver after taking Erlocip. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.

Moderate
What is the effect of Erlocip 150 Tablet on the Heart?

Using Erlocip does not have any harmful effects on the heart.

Safe

Erlocip 150 Tablet Contraindications

If you are suffering from any of the following diseases, you should not take Erlocip 150 Tablet unless your doctor advises you to do so -

COPD (Chronic Obstructive Pulmonary Disease)
Liver Disease
Kidney Disease
Dehydration
Peptic Ulcer
Lung Disease

Frequently asked Questions about Erlocip 150 Tablet

Is this Erlocip 150 Tablet habit forming or addictive?

Erlocip 150 Tablet is not addictive in nature.

No
Is it safe to drive or operate heavy machinery when consuming?

No, you should do not do anything that requires concentration and attention as the Erlocip 150 Tablet can make you feel drowsy.

Dangerous
Is it safe?

Erlocip 150 Tablet is safe but it is important to consult a doctor before taking it.

Safe, but take only on Doctor's advise
Is it able to treat mental disorders?

No, Erlocip 150 Tablet cannot treat any kind of mental disorder.

No

Erlocip 150 Tablet Interactions with Food and Alcohol

Interaction between Food and Erlocip 150 Tablet

Erlocip 150 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.

Mild
Interaction between Alcohol and Erlocip 150 Tablet

Due to lack of research, there is no information about the side effects of taking Erlocip 150 Tablet with alcohol.

Unknown

See all substitutes for Erlocip

Zyceva 100 Tablet - ₹2860
Tarceva Tablet - ₹40300
Erlotec 150 Tablet - ₹5950
Erlotec 100 Tablet - ₹4550
Erlocip 150 Tablet - ₹5235
Erlocip 100 Tablet - ₹4662
Erlotinib Tablet - ₹12000
Zyceva 150 Tablet - ₹3330
Tyrokinin 150 Tablet - ₹5580
Tyrokinin 100 Tablet - ₹18990
Erleva 100 Mg Tablet - ₹3222
Lortinib 150 Mg Tablet - ₹11159
Erlotib 150 Tablet - ₹2975
Erlostar Tablet - ₹25500
Erlonat 150 Tablet - ₹11900
Erlonat 100 Tablet - ₹9990
Erlokem 150 Tablet - ₹10908
Erlokem 100 Tablet - ₹8100
Erleva 150 Mg Tablet - ₹5280

This medicine data has been created by -

Vikas Chauhan

B.Pharma, Pharmacy
5 Years of Experience

References

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tarceva® (erlotinib)

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 514-516

Erlocip 150 Tablet